Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Haakonsson, Stine Jessen
2009.
‘Learning by importing’ in global value chains: upgrading and South–South strategies in the Ugandan pharmaceutical industry.
Development Southern Africa,
Vol. 26,
Issue. 3,
p.
499.
Venkatesh, Kartik K.
Mayer, Kenneth H.
and
Carpenter, Charles C.J.
2012.
Low-Cost Generic Drugs Under The President’s Emergency Plan For AIDS Relief Drove Down Treatment Cost; More Are Needed.
Health Affairs,
Vol. 31,
Issue. 7,
p.
1429.
Abbas, Muhammad Zaheer
2013.
Pros and Cons of Compulsory Licensing: An Analysis of Arguments.
International Journal of Social Science and Humanity,
p.
254.
Wiernikowski, John T.
and
Barr, Ronald D.
2014.
Pediatric Hematology-Oncology in Countries with Limited Resources.
p.
129.
Wiernikowski, John T.
and
MacLeod, Stuart
2014.
Regulatory and logistical issues influencing access to antineoplastic and supportive care medications for children with cancer in developing countries.
Pediatric Blood & Cancer,
Vol. 61,
Issue. 8,
p.
1513.
Pam, Adamu Audu
2014.
The Centrality of Intellectual Property Law in the Fight Against Ebola Virus in West Africa..
SSRN Electronic Journal,
Hoffman, Steven J.
and
So, Karen
2015.
Assessing 15 Proposals for Promoting Innovation and Access to Medicines
Globally.
Annals of Global Health,
Vol. 80,
Issue. 6,
p.
432.
Ramani, Shyama V.
and
Urias, Eduardo
2015.
Access to critical medicines: When are compulsory licenses effective in price negotiations?.
Social Science & Medicine,
Vol. 135,
Issue. ,
p.
75.
Son, Kyung-Bok
2019.
Importance of the intellectual property system in attempting compulsory licensing of pharmaceuticals: a cross-sectional analysis.
Globalization and Health,
Vol. 15,
Issue. 1,
ÖZKÖK GÖKMEN, Başak
2021.
COVID-19 AŞILARI ÜZERİNDEKİ PATENT HAKKININ KAPSAMININ KAMU SAĞLIĞI AÇISINDAN DEĞERLENDİRİLMESİ.
Ankara Hacı Bayram Veli Üniversitesi Hukuk Fakültesi Dergisi,
Vol. 25,
Issue. 3,
p.
161.
Lipkus, Nathaniel
and
Black, Madison
2022.
NAFTA 2.0.
p.
109.
Demir, Ezgi
and
Bican, Peter M.
2023.
Patents and Sustainable Medical Treatment in Developing Countries: Lessons from COVID-19 Vaccines.
Sustainability,
Vol. 15,
Issue. 4,
p.
3121.
Forere , Malebakeng
2024.
Does Article 4(1)(a) of the Marrakesh Treaty Require Limitation to Adaptation Rights? Blind SA v Minister of Trade, Industry and Competition (CCT 320/21) [2022] ZACC 33 (21 September 2022).
Potchefstroom Electronic Law Journal,
Vol. 27,
Issue. ,